Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial

CONTEXT: Daily growth hormone (GH) injections can be burdensome for patients and carers. Somapacitan is a long-acting, reversible albumin-binding GH derivative in development for once-weekly administration in patients with growth hormone deficiency (GHD). OBJECTIVE: The objective of this study is to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sävendahl, Lars, Battelino, Tadej, Brod, Meryl, Højby Rasmussen, Michael, Horikawa, Reiko, Juul, Rasmus Vestergaard, Saenger, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069655/
https://www.ncbi.nlm.nih.gov/pubmed/31917835
http://dx.doi.org/10.1210/clinem/dgz310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069655/
https://www.ncbi.nlm.nih.gov/pubmed/31917835
http://dx.doi.org/10.1210/clinem/dgz310

Ejemplares similares